1. Introduction/Overview The renin-angiotensin-aldosterone system (RAAS) constitutes a critical hormonal cascade that regulates blood pressure, fluid volume, and electrolyte balance. Its dysregulation is implicated in the pathophysiology of several major cardiovascular and renal diseases, including hypertension, heart failure, chronic kidney disease, and diabetic nephropathy. Consequently, pharmacological agents designed to modulate this system represent a cornerstone … Read more

Introduction/Overview The pharmacology of drugs of abuse represents a critical intersection of neurobiology, pharmacokinetics, and clinical medicine. Substance use disorders constitute a major public health burden, characterized by a compulsive pattern of drug-seeking and use despite significant harmful consequences. Understanding the pharmacological principles underlying these agents is essential for healthcare professionals to manage intoxication, withdrawal, … Read more

Introduction/Overview The pharmacology of drugs of abuse encompasses the study of substances that are used non-medically for their psychoactive effects, leading to a high potential for dependence and addiction. This field integrates principles of neuropharmacology, pharmacokinetics, and clinical medicine to understand how these substances alter brain function and behavior. Substance use disorders represent a significant … Read more

Introduction/Overview The pharmacological modulation of central nervous system (CNS) arousal and cognitive function represents a critical area of therapeutics with applications spanning neuropsychiatry, neurology, and general medicine. CNS stimulants and nootropics comprise a diverse group of agents that enhance cortical activity, alertness, attention, and various domains of executive function. The clinical relevance of these drugs … Read more

Introduction/Overview Central nervous system (CNS) stimulants and nootropics constitute a pharmacologically diverse group of agents that enhance cortical arousal, attention, and cognitive function. These drugs hold significant clinical importance in the management of several neurological and psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), narcolepsy, and cognitive impairment. The therapeutic application of these substances is balanced by … Read more

Introduction/Overview Alzheimer’s disease represents the most prevalent form of dementia, characterized by progressive neurodegeneration leading to cognitive decline, functional impairment, and behavioral disturbances. The pharmacological management of this condition is centered on symptomatic treatment, with emerging therapies targeting underlying disease pathology. The clinical relevance of these agents is substantial, as they aim to modify the … Read more

Introduction/Overview Parkinsonism constitutes a clinical syndrome characterized by the cardinal motor features of bradykinesia, resting tremor, rigidity, and postural instability. The most prevalent cause is idiopathic Parkinson’s disease (PD), a progressive neurodegenerative disorder. The primary neuropathological hallmark of PD is the degeneration of dopaminergic neurons within the substantia nigra pars compacta, leading to a profound … Read more

Introduction/Overview Parkinsonism constitutes a clinical syndrome characterized by the cardinal motor features of bradykinesia, resting tremor, rigidity, and postural instability. While idiopathic Parkinson’s disease (PD) is the most prevalent cause, parkinsonism may also arise from other neurodegenerative disorders, vascular insults, or exposure to certain drugs. The neuropathological hallmark of PD is the progressive degeneration of … Read more